BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20200308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20201101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20210314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20211107T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T150000
DTEND;TZID=UTC:20210630T160000
DTSTAMP:20260608T192700
CREATED:20210602T225615Z
LAST-MODIFIED:20210602T225615Z
UID:1973-1625065200-1625068800@thebiocalendar.com
SUMMARY:Startup Legal Bootcamp Series with Matt Crowley - Marriage and Divorce for Co-Founders
DESCRIPTION:Marriage and Divorce for Co-Founders\nWednesday\, June 30\, 2021\, 3-4pm \nThinking about partnering up with colleagues to start your first business? Learn about time-tested strategies for getting the co-founder relationship off to a healthy start.
URL:https://thebiocalendar.com/event/startup-legal-bootcamp-series-with-matt-crowley-marriage-and-divorce-for-co-founders/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T110000
DTEND;TZID=UTC:20210630T120000
DTSTAMP:20260608T192700
CREATED:20210602T230822Z
LAST-MODIFIED:20210602T231403Z
UID:1982-1625050800-1625054400@thebiocalendar.com
SUMMARY:Berkeley Lab 90th Anniversary - Virtual Tour of the Joint Genome Institute (June)
DESCRIPTION:In 2021\, Berkeley Lab’s 90th year\, we’re celebrating past achievements and imagining tomorrow’s solutions. As part of this celebration we are highlighting our facilities like never before! In this pre-scheduled\, live\, interactive\, presentation by Lab staff and scientists you will learn about the Joint Genome Institute. \nThe mission of the U.S. Department of Energy (DOE) Joint Genome Institute (JGI)\, a DOE Office of Science User Facility of Berkeley Lab\, is to advance genomics in support of the DOE missions related to clean energy generation and environmental characterization and cleanup. Supported by the DOE Office of Science\, the JGI unites the expertise at Berkeley Lab\, Lawrence Livermore National Laboratory\, and the HudsonAlpha Institute for Biotechnology. During this virtual tour\, you will learn how JGI provides integrated high-throughput sequencing\, DNA design and synthesis\, metabolomics and computational analysis that enable systems-based scientific approaches to these challenges. \nJoin a Zoom Webinar for approximately 60 minutes including a live presentation and Q&A!
URL:https://thebiocalendar.com/event/berkeley-lab-90th-anniversary-virtual-tour-of-the-joint-genome-institute-june/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T090000
DTEND;TZID=UTC:20210630T100000
DTSTAMP:20260608T192700
CREATED:20210608T233657Z
LAST-MODIFIED:20210608T233657Z
UID:2001-1625043600-1625047200@thebiocalendar.com
SUMMARY:California Life Sciences: Conversation with Thought Leaders: Health Equity
DESCRIPTION:Join California Life Sciences for our Conversation with Thought Leaders: Health Equity\, which will explore the importance of increasing health access to underserved communities\, overcoming vaccine hesitancy. We’ll also explore how the life sciences community can help tackle other hurdles to ensure equitable and safe health care access for patients and their families.
URL:https://thebiocalendar.com/event/california-life-sciences-conversation-with-thought-leaders-health-equity/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/251288_CLS_Thought_LI-FB.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210629T170000
DTEND;TZID=UTC:20210629T193000
DTSTAMP:20260608T192700
CREATED:20210616T172744Z
LAST-MODIFIED:20210616T172744Z
UID:2038-1624986000-1624995000@thebiocalendar.com
SUMMARY:BVS' Biotech Community Event at the Green Flash Brewery
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at the Green Flash Brewery. \nThese events are always very popular and we get representation from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \nThe event is being promoted as a special Biotech Community Event sponsored by the best scientific suppliers in the industry along with it being a wonderful way for scientists and science vendors to network in a relaxed evening venue. \nThe event will be a combination of vendor exhibits\, tacos and beer. We will have extra special raffle prizes and expect an excellent turnout. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-the-green-flash-brewery/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210629T130000
DTEND;TZID=UTC:20210629T140000
DTSTAMP:20260608T192700
CREATED:20210623T221214Z
LAST-MODIFIED:20210623T221216Z
UID:2067-1624971600-1624975200@thebiocalendar.com
SUMMARY:Benefits of System Validation for Life Sciences Companies
DESCRIPTION:Join RSM Senior Director\, Michael Breggar\, and Director\, Steve Kemler\, to learn how a pragmatic computer system validation can be beneficial for your entire organization. Many people view regulatory compliance activities as something that simply “has to be done;” however\, there are also many areas of value add along this transformational path. What if you took the process of validation as a way to improve and streamline your operations? \nJoin the RSM team to see a demonstration of how our Life Sciences clients are improving their businesses while also meeting regulatory requirements; often times leveraging the leading cloud-based ERP – NetSuite.
URL:https://thebiocalendar.com/event/benefits-of-system-validation-for-life-sciences-companies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/custom_logoImageFile.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210628T160000
DTEND;TZID=UTC:20210628T180000
DTSTAMP:20260608T192700
CREATED:20210616T184456Z
LAST-MODIFIED:20210616T184456Z
UID:2048-1624896000-1624903200@thebiocalendar.com
SUMMARY:SoCalBio Networking Forum: COVID-9; Accelerator / Disrupter / Game-Changer?
DESCRIPTION:When COVID-19 hit last year\, it unveiled many of the vulnerabilities of the US healthcare system and its supply chain. In the process\, it also gave a second life to the search for pathways to institutionalize a value-based healthcare regime to improve patient outcomes and reduce the cost of care. \nJoin us for an inspiring keynote presentation to be followed by a lively discussion of the long-term impact of COVID\, and how innovators in the Medtech\, biotech\, and digital health industries can play a role in driving the transformation to a value-based healthcare system. \nAbout Richard Gannotta: \nRichard Gannotta\, NP\, DHA\, FACHE is a recognized leader in the health sector. He is the Chief Healthcare Administrative Officer at Masimo\, a global technology company that develops and manufactures a variety of innovative noninvasive patient monitoring technology and clinical solution sets designed to improve patient outcomes and reduce the cost of care.
URL:https://thebiocalendar.com/event/socalbio-networking-forum-covid-9-accelerator-disrupter-game-changer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210623T160000
DTEND;TZID=UTC:20210623T190000
DTSTAMP:20260608T192700
CREATED:20210609T034741Z
LAST-MODIFIED:20210609T034743Z
UID:2009-1624464000-1624474800@thebiocalendar.com
SUMMARY:Venture Capital 101
DESCRIPTION:If you are interested in learning more about how VC investing works\, what their process is for engaging with a life science startup\, and how they manage their portfolios; then you will not want to miss our next event. Please join us on June 23rd from 4-5PM EDT for a talk with Riley Rodgers from Valia Ventures as he explains the ins and outs of VC investing followed by open networking from 5-7PM EDT via the Grapevine Network. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://thebiocalendar.com/event/venture-capital-101/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/Purple-Zodiac-Sign-Animated-Presentation-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210623T150000
DTEND;TZID=UTC:20210623T160000
DTSTAMP:20260608T192700
CREATED:20210602T225516Z
LAST-MODIFIED:20210602T225516Z
UID:1972-1624460400-1624464000@thebiocalendar.com
SUMMARY:Startup Legal Bootcamp Series with Matt Crowley - Equity and Dilution Basics
DESCRIPTION:Equity and Dilution Basics\nWednesday\, June 23\, 2021\, 3-4pm \nEver wonder about the difference between a convertible note and a SAFE? Here’s your chance to learn from a veteran venture lawyer about all of the options that founders have for financing their businesses with equity. Participants will also get a walk-through on how dilution works and why it’s ultimately nothing to fear.
URL:https://thebiocalendar.com/event/startup-legal-bootcamp-series-with-matt-crowley-equity-and-dilution-basics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20210623T110000
DTEND;TZID=America/Denver:20210623T130000
DTSTAMP:20260608T192700
CREATED:20210302T000357Z
LAST-MODIFIED:20210602T231449Z
UID:1883-1624446000-1624453200@thebiocalendar.com
SUMMARY:PBSS Free Online Symposium: Highlights from 2020’s FDA New Drug Approvals
DESCRIPTION:In this presentation we summarize 2020’s cohort of new drugs approved by the FDA in 2020. Statistics on the overall cohort will be discussed\, followed by a short summary of key features of approved drugs\, and a few case studies highlighting interesting discovery or development stories from the cohort.
URL:https://thebiocalendar.com/event/pbss-free-online-symposium-highlights-from-2020s-fda-new-drug-approvals/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/03/PBSS-logo-SFBayai-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210623
DTEND;VALUE=DATE:20210625
DTSTAMP:20260608T192700
CREATED:20210419T230528Z
LAST-MODIFIED:20210617T215702Z
UID:1934-1624406400-1624579199@thebiocalendar.com
SUMMARY:Fearless in Pharma Virtual Summit
DESCRIPTION:  \n \nBROCHURE
URL:https://thebiocalendar.com/event/fearless-in-pharma-virtual-summit/
CATEGORIES:Featured
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210622T100000
DTEND;TZID=UTC:20210623T170000
DTSTAMP:20260608T192700
CREATED:20210520T184221Z
LAST-MODIFIED:20210520T184221Z
UID:1963-1624356000-1624467600@thebiocalendar.com
SUMMARY:8th world congress on Chemical Engineering and Catalysis
DESCRIPTION:The Chemical Engineering Congress 2021 will provide attendees with the latest chemical updates\, the latest advances in chemical engineering and catalysis. This Chemical Engineering Conference will help chemists\, and chemical engineers around the world to share their experiences and learn from best practices\, strengthen chemical and catalytic collaborative research\, and connect with each other. Outstanding speakers\, discussion of new technologies and modern catalysis updates are unique attributes of this catalysis conference. Dedicated discussions in chemistry\, catalysis\, physics\, nanotechnology and biochemical will additionally help participants to improve their knowledge. \nBy attending the Chemical Engineering Congress 2021\, Webinar can get the insights of: \nThe Conference gives an incredible chance to getting interfaced for future coordinated efforts where the vast majority can assist each other with uncovering thoughts and flash motivation.\nTo learn and discover new things in your order of revenue.\nMeet specialists and influencers.\nAttending to a meeting permits you to develop and adds your exploration esteem.\nOrganization with pioneers and influencers from the logical\, scholarly and R&D people group.
URL:https://thebiocalendar.com/event/8th-world-congress-on-chemical-engineering-and-catalysis/
LOCATION:CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210622T100000
DTEND;TZID=UTC:20210622T120000
DTSTAMP:20260608T192700
CREATED:20210602T192952Z
LAST-MODIFIED:20210602T193004Z
UID:1970-1624356000-1624363200@thebiocalendar.com
SUMMARY:FAST Advisory Program: Spring Closing Showcase
DESCRIPTION:The FAST Advisory Program provides selected startups and entrepreneurs with intensive team review and coaching to perfect their business model and product development plans\, and to build a compelling commercialization strategy. Experienced entrepreneurs\, product and business experts (which may include clinical development\, regulatory\, reimbursement and business development specialists) advise the selected Fellows during a ten-to-twelve week program\, culminating in a final FAST Showcase presentation to a broad audience that includes potential investors and partners. \n 
URL:https://thebiocalendar.com/event/fast-advisory-program-spring-closing-showcase/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210624
DTSTAMP:20260608T192700
CREATED:20210610T191944Z
LAST-MODIFIED:20210610T191944Z
UID:2019-1624320000-1624492799@thebiocalendar.com
SUMMARY:Next Gen: What’s beyond the leading edge of biotech and pharma?
DESCRIPTION:We’re looking for the next generation.\nNew waves of cancer targets. Novel approaches to cell and gene therapies. Cutting-edge technologies set to change biopharma manufacturing. Even a new cohort of up-and-coming industry leaders. We’ll delve into all these subjects and more June 22-23 at Fierce’s next virtual event. \nAnd take a walk with our new virtual event platform Brella\, where you can schedule one-on-one meetings\, participate in group chats with speakers\, partners and attendees. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n 
URL:https://thebiocalendar.com/event/next-gen-whats-beyond-the-leading-edge-of-biotech-and-pharma/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210626
DTSTAMP:20260608T192700
CREATED:20210616T170513Z
LAST-MODIFIED:20210616T170513Z
UID:2029-1624320000-1624665599@thebiocalendar.com
SUMMARY:Virtual 2021 Cell Cycle Meeting
DESCRIPTION:Sessions start at 8am PDT and end at 1pm PDT (-7 UTC)\nVirtual – Zoom meeting information will be provided one week prior to the event. \nAbstract Deadline: Abstract submission is now closed.\nRegistration Deadline: Registration is now closed. \nMeeting Topics\n\nGrowth and Proliferation\nDNA Replication\nGenome Stability\nCell Cycle Switches and Division\nMitosis\nCell Cycle and Development\n\nSpeaker Names\n\nNEWPORT LECTURE: Sue Biggins\, Fred Hutchinson Cancer Research Center\nBrenda Andrews\, University of Toronto\nSteve Bell\, MIT\nFred Cross\, Rockefeller University\nRob de Bruin \,University College London\nChristian Haering\, European Molecular Biology Laboratory\nRebecca Heald\, UC Berkeley\nToru Hirota\, Cancer Institute/JFCR\, Tokyo\nMike Lampson\, University of Pennsylvania\nGustavo Leone\, Medical College of Wisconsin\nMart Loog\, University of Tartu\nKaren Oegema\, UC San Diego\nOfer Shoshani\, UC San Diego\nZuzana Storchová\, Technische Universität Kaiserslautern\nBik Tye\, Hong Kong University of Science and Technology
URL:https://thebiocalendar.com/event/virtual-2021-cell-cycle-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210623
DTSTAMP:20260608T192700
CREATED:20210507T161332Z
LAST-MODIFIED:20210507T161332Z
UID:1944-1624320000-1624406399@thebiocalendar.com
SUMMARY:Milner Therapeutics Symposium 2021
DESCRIPTION:In light of the ongoing situation around COVID-19\, the 2021 Symposium has been moved online\, taking place on Tuesday 22nd June. \nWe have been busy adapting the programme to maximize opportunities for making new connections. In addition to a fantastic programme of speakers\, there will be interactive networking sessions and a forum for arranging individual meetings. Our aim is to bring scientific connections back to life\, and help you use this platform as a springboard for initiating new collaborations. \nThis one-day online event is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments. Presentations will be followed by a live Q&A\, aiming to accommodate and engage a larger international audience. \nRegistration to the Symposium is free\, and open to academics and Milner affiliated companies only. \nPlease do not register for the Symposium if your organisation is not currently affiliated with the Milner Therapeutics Institute. \nPlease e-mail us at symposium@milner.cam.ac.uk to discuss eligibility. \nDelegates who are registered via this page will receive individual log-ins to the Symposium.
URL:https://thebiocalendar.com/event/milner-therapeutics-symposium-2021/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210621T100000
DTEND;TZID=UTC:20210621T110000
DTSTAMP:20260608T192700
CREATED:20210611T175123Z
LAST-MODIFIED:20210611T175123Z
UID:2023-1624269600-1624273200@thebiocalendar.com
SUMMARY:Biopharma Dealmaking in 2021: Trends and Transformation
DESCRIPTION:In this exclusive webinar\, Chris Dokomajilar\, founder and CEO of DealForma\, and Gilles Toulemonde\, CEO of Inova\, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They’ll discuss what deals have been done so far in 2021\, identify some of the difficulties that pharma companies are experiencing in attracting biotechs\, and explain what to watch in deal making and partnering best practices for the second half of 2021.
URL:https://thebiocalendar.com/event/biopharma-dealmaking-in-2021-trends-and-transformation/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210621
DTEND;VALUE=DATE:20210624
DTSTAMP:20260608T192700
CREATED:20210617T215808Z
LAST-MODIFIED:20210617T215808Z
UID:2057-1624233600-1624492799@thebiocalendar.com
SUMMARY:Proactive GCP Compliance
DESCRIPTION:Effective Risk-Based Approaches to Optimize Clinical Quality and Achieve Inspection Readiness\nThe pandemic forced clinical operations to adapt quickly\, so research could continue\, but what are the implications for quality?\nHow did you ensure trial integrity as processes and operations were disrupted by new safety mandates?\nWhat documentation will regulators request for research that was impacted by the pandemic? \nWe’ve developed a three-day virtual experience on June 21-23\, offering a variety of educational and networking opportunities to address these questions and more. During this live virtual experience\, you’ll have the opportunity to interact with your peers and engage with our expert speaking faculty. Leave the event with a robust knowledge on where we stand as an industry and an understanding of the path forward. If you can’t make the live dates of the conference\, still register\, you can view on-demand at your leisure.
URL:https://thebiocalendar.com/event/proactive-gcp-compliance/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210621
DTEND;VALUE=DATE:20210622
DTSTAMP:20260608T192700
CREATED:20210218T201436Z
LAST-MODIFIED:20210218T201436Z
UID:1864-1624233600-1624319999@thebiocalendar.com
SUMMARY:From The Laboratory To Leadership
DESCRIPTION:From The Laboratory To Leadership turns science-minded managers into capable business leaders. That means they’ll get the core management skills they need to fully leverage your company’s human capital. \nIn this four-day program\, developed exclusively for managers in scientific fields\, participants will learn how to … \n– Create productive teams in a challenging matrix-based team environment \n– Clearly communicate goals and expectations resulting in a highly engaged and productive workforce \n– Run effective meetings that drive results and minimize the time away from your employees highest payoff activities \n– Resolve conflict and reduce stress through an increased understanding of personality and work styles \n– Leverage limited resources to meet major milestones \n– Delegate with confidence while better utilizing your resources and talent \n– Conduct performance reviews and motivate employees through clear communication\, employee development plans\, and the celebration of successes. \nThe program includes company and industry-relevant case studies\, practical and engaging exercises\, down-loadable support tools for each session\, and a manual designed to personalize the training for each participant. \nAdd it all up\, and From The Laboratory To Leadership brings out the best in your managers – which brings out the best performance from your company. It’s no wonder this program has served more than 6\,500 scientific and engineering managers from 600 life science and technology organizations\, including Bio-Rad Laboratories\, Axio Research\, Sutro Biopharma\, DuPont Industrial Biosciences\, Genomatica\, Novozymes\, and Janssen Research and Development\, LLC. \nSyllabus and FAQ’s \nInstructor Bio \n\n\n\nPrice of Admission\n\n\n\n\n\n\n\nMember \nToday’s Price: $2\,795.00\n\n\n\n\nImportant Dates\nAmount\n\n\nRegistration cost\n$2\,795.00\n\n\nRefund before Friday\, April 30\, 2021\n$2\,795.00\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNon-Member \nToday’s Price: $3\,295.00\n\n\n\n\nImportant Dates\nAmount\n\n\nRegistration cost\n$3\,295.00\n\n\nRefund before Friday\, April 30\, 2021\n$3\,295.00
URL:https://thebiocalendar.com/event/from-the-laboratory-to-leadership-7/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210617T160000
DTEND;TZID=UTC:20210617T170000
DTSTAMP:20260608T192700
CREATED:20210507T161509Z
LAST-MODIFIED:20210507T161509Z
UID:1945-1623945600-1623949200@thebiocalendar.com
SUMMARY:QB3 Webinar: John York\, Impossible Foods
DESCRIPTION:As Chief Science Officer at Impossible Foods\, Dr. John York\, PhD\, leads a fast-growing R&D team expected to double in size in 2021. Before joining the company in January\, York served as the Chair of the Department of Biochemistry and a Professor of Biochemistry at Vanderbilt University from 2012 to 2020\, where his laboratory paved the way for discoveries in protein structure and function\, cell signaling and molecular genetics. He joined Impossible Foods because\, as he says\, “the opportunity to use biochemistry to save the planet is a spectacular motivation.” Now\, Dr. York is finding a new lab and headquarters for the company’s R&D operations in the Bay Area\, and he’s leading the company’s world-class scientists as they develop the next generation of sustainable ingredients to solve our ecological crisis. Join this talk to learn about his research and how he is approaching his new role.
URL:https://thebiocalendar.com/event/qb3-webinar-john-york-impossible-foods/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210617T090000
DTEND;TZID=UTC:20210617T120000
DTSTAMP:20260608T192700
CREATED:20210520T190515Z
LAST-MODIFIED:20210602T231359Z
UID:1964-1623920400-1623931200@thebiocalendar.com
SUMMARY:2021 CAPCaT Big Company/Little Company Showcase
DESCRIPTION:See 9 breakthrough point-of-care innovations and learn about strategic partnership and grant opportunities that can accelerate YOUR startup. \n  \n\n\n\n\n\n\n\n\nFor the second straight year\, The Center for Advancing Point of Care Technologies (CAPCaT) in Heart\, Lung\, Blood\, and Sleep Disorders is pleased to present this high-energy\, high-value event for life sciences startups. Join us and open the doors to big company/little company strategic partnerships and grant funding opportunities.\nWho should attend?\n\nLife sciences startups seeking corporate strategic partnerships.\nAcademic researchers seeking to build their early-stage innovation through NIH grant funding.\nLife sciences entrepreneurs seeking an opportunity to network with potential corporate strategic partners.\nInnovators\, investors\, academics\, students\, and anyone\, anywhere\, interested in the future direction of vital point-of-care medtech.
URL:https://thebiocalendar.com/event/2021-capcat-big-company-little-company-showcase/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210616T150000
DTEND;TZID=UTC:20210616T160000
DTSTAMP:20260608T192700
CREATED:20210602T225356Z
LAST-MODIFIED:20210602T225356Z
UID:1971-1623855600-1623859200@thebiocalendar.com
SUMMARY:Startup Legal Bootcamp Series with Matt Crowley - How Investors View Valuations
DESCRIPTION:How Investors View Valuations\nWednesday\, June 16\, 2021\, 3-4pm. \nCome take advantage of the opportunity to hear about how valuations for startups are negotiated. We will learn how investors see the world and the factors they take into account when placing a bet on your company.
URL:https://thebiocalendar.com/event/startup-legal-bootcamp-series-with-matt-crowley-how-investors-view-valuations/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210616
DTEND;VALUE=DATE:20210619
DTSTAMP:20260608T192700
CREATED:20210610T190546Z
LAST-MODIFIED:20210610T190546Z
UID:2018-1623801600-1624060799@thebiocalendar.com
SUMMARY:Antiepileptic Drug and Device Trials
DESCRIPTION:The 16th conference on Antiepileptic Drug and Device Trials is held every two years and sponsored by The Epilepsy Study Consortium in collaboration with the University of Pennsylvania and the Epilepsy Foundation. \nIf you have any questions about the conference\, please contact Mary Ann Brodie [brodie@epilepsyconsortium.org] or Tracy DeVito [devito@epilepsyconsortium.org] at the Epilepsy Study Consortium. \nTHE IN-PERSON MEETING IS OPEN TO ALL THOSE WHO ARE FULLY VACCINATED AGAINST COVID-19. ALL OTHERS ARE WELCOME TO JOIN THE MEETING VIRTUALLY.
URL:https://thebiocalendar.com/event/antiepileptic-drug-and-device-trials/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210615T180000
DTEND;TZID=UTC:20210615T220000
DTSTAMP:20260608T192700
CREATED:20210603T015621Z
LAST-MODIFIED:20210603T015622Z
UID:1987-1623780000-1623794400@thebiocalendar.com
SUMMARY:Biotech Networks Virtual Speed Networking
DESCRIPTION:The San Diego Biotechnology Network (SDBN) began connecting life science professionals in 2008\, and expanded into the California bay area  and Los Angeles in late 2019 and into virtual events in 2020. Like other communities\, we have realized the power of connecting virtually. Virtual networking tools have advanced to the point where geographic boundaries are less of an obstacle to accelerating development. \nSDBN Founder Mary Canady is pleased to announce the founding of Biotech Networks\, which will connect life science professionals within and between existing and emerging geographical life science hubs. The new Biotech Networks organization will be  based on the SDBN model\, and will launch with a virtual speed networking event June 15th 2021 during the BIO International Convention. Combining the SDBN’s expertise in connecting many thousands of life science professionals\, with new online tools and the expansion into new regions\, will catalyze biotech development at a level never before achieved. \nAt this event the Boston Cambridge: Biotech Networks hub will also be launched\, expanding the organization into one of the major US geographical regions for life science\, and creating the first-of-its-kind network outside of California. In the near future\, Biotech Networks will be expanding the virtual and in-person networking model developed in California into different regionally-focused hubs across the US and globally. \nCOVID-19 changed the world in many ways\, and while geographic hubs will always facilitate biotech development through a consolidation of research institutions\, talent\, and capital\, there is now an even greater opportunity for life science professionals to accelerate research and product development virtually from any location in the world. Biotech Networks plans to democratize the connections both within and between regions through the development of both regional and topic-based member-driven communities. \nParticipants at the June 15th Biotech Networks Virtual Speed Networking event will make many meaningful connections with other life science professionals through online 1-on-1 speed networking activities which SDBN has been developing over their 13 year history. The event will also feature location and topic-based roundtables\, where guests can informally network. In addition\, attendees will participate in determining the future of Biotech Networks through interactive sessions and polls. In addition to networking\, activities within and between each region may include partnering\, conferences\, mentoring\, and career fairs. \nTickets are only $20 to attend the event\, and 50% of the proceeds will be donated to Unicef to provide relief to COVID-19 victims in India. We will begin the event at 3 p.m. US PT/6 p.m. US ET to accommodate different time zones\, and the welcome presentation will be available for viewing at any time for those who may need to log in late. Speed networking will continue until 7 p.m. US PT/10 p.m. US ET. Instructions for using the event platform will also be provided.
URL:https://thebiocalendar.com/event/biotech-networks-virtual-speed-networking/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210615
DTEND;VALUE=DATE:20210617
DTSTAMP:20260608T192700
CREATED:20210406T181104Z
LAST-MODIFIED:20210406T181214Z
UID:1911-1623715200-1623887999@thebiocalendar.com
SUMMARY:Animal Health USA 2021
DESCRIPTION:Serving Unmet Medical Needs in Veterinary Medicine Through Business Partnering and Investment \n\nWHY ATTEND\n\n\n\n\n\nThe 5th Animal Health Innovation USA is the must attend networking event in North America for innovators with new solutions to support the detection\, prevention or treatment of diseases in animals. \nOur mission is to showcase the most exciting investment opportunities in the sector and connect those businesses with financial investors and strategic corporate partners. \nAlongside our investment pitches\, we include keynote presentations and host CEO-level panel discussions that address the most pressing trends and market dynamics of the animal health\, nutrition and productions industries\, across all species. \n\n\n\n\nDownload Agenda 
URL:https://thebiocalendar.com/event/1911/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/04/AH-Innovation-USA-Logo-CLR.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210614
DTEND;VALUE=DATE:20210619
DTSTAMP:20260608T192700
CREATED:20210413T191430Z
LAST-MODIFIED:20210413T191532Z
UID:1921-1623628800-1624060799@thebiocalendar.com
SUMMARY:BIO Digital
DESCRIPTION:Join The World’s Largest Global Biotech Partnering Experience\nBIO Digital is the world’s largest virtual biotech partnering and education event\, convening thousands of global biotech leaders and innovators. Join us in our efforts to accelerate a BIO-Revolution through global partnerships\, collaboration\, and thought leadership. \nNow more than ever\, the world is counting on us to come together to advance innovation and discovery.  Join us at BIO Digital 2021 this June! \nBIO Digital\nJune 10-11 & 14-18\, 2021
URL:https://thebiocalendar.com/event/bio-digital-2/
CATEGORIES:Featured
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210611T153000
DTEND;TZID=UTC:20210611T193000
DTSTAMP:20260608T192700
CREATED:20210507T161805Z
LAST-MODIFIED:20210602T231355Z
UID:1946-1623425400-1623439800@thebiocalendar.com
SUMMARY:SoCalBio Innovation Catalyst Program
DESCRIPTION:This meeting is one of many screening forums organized by SoCalBio to select the best device\, biotech\, and digital health company candidates to make presentations during: \n\nThe 23rd Annual SoCalBio Conference on October 20-22\, 2021\n5th SoCalBio Digital Health Conference on March 23-25\, 2022
URL:https://thebiocalendar.com/event/socalbio-innovation-catalyst-program/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210610T140000
DTEND;TZID=UTC:20210610T150000
DTSTAMP:20260608T192700
CREATED:20210609T004441Z
LAST-MODIFIED:20210609T004530Z
UID:2007-1623333600-1623337200@thebiocalendar.com
SUMMARY:California Reopening: What You Need to Know | Biocom California
DESCRIPTION:Biocom California invites you to a upcoming webinar where we will review the upcoming changes to Cal/OSHA’s Emergency Temporary Standards (ETS) anticipated to go into effect in June. The discussion will cover modifications to the ETS\, how the ETS updates will interact with the newly relaxed CDC guidelines for fully vaccinated individuals\, and the bottom-line impact on returning employees to the office. \nPresenters:\nJim Fessenden\, Employment Partner\, Fisher Phillips LLP\nChad Hansen\, MS\, MBA\, CIH\, CSP\, CPE\, President and CEO\, Occupational Services\, Inc. \n*HRCI and SHRM credits will be given for attending this webinar.
URL:https://thebiocalendar.com/event/california-reopening-what-you-need-to-know-biocom-california/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/servlet-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210610T103000
DTEND;TZID=UTC:20210611T173000
DTSTAMP:20260608T192700
CREATED:20201024T022400Z
LAST-MODIFIED:20210416T182825Z
UID:1114-1623321000-1623432600@thebiocalendar.com
SUMMARY:RARE Drug Development Symposium
DESCRIPTION:The RARE Drug Development Symposium is a two-day interactive event in partnership with The Penn Medicine Orphan Disease Center that focuses on educating both beginners and advanced participants on the drug development process. Here\, all members of the rare disease community are encouraged to explore their role in the rare disease drug development process in new and innovative ways. \nThis personalized experience is dedicated to empowering the rare disease community to continue to push forward on necessary treatments and cures\, despite experiencing setbacks as a result of COVID-19. We are excited to offer poster presentations and speakers on engaging new topics\, including CureAccelerator Live! \nStay tuned for updates and announcements for our 2021 dates and location. In the meantime\, you can see highlights from the 2020 RARE Drug Development Symposium here\, or discover what’s next in drug development in the RARE Drug Development 2020 Report.
URL:https://thebiocalendar.com/event/rare-drug-development-symposium/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/10/RDDS-virtual-logo-e1588375289672.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210610T095500
DTEND;TZID=UTC:20210610T152000
DTSTAMP:20260608T192700
CREATED:20210211T023715Z
LAST-MODIFIED:20210211T025934Z
UID:1774-1623318900-1623338400@thebiocalendar.com
SUMMARY:Free Virtual Conference - Precision Medicine & Rare Disease
DESCRIPTION:Patients living with rare diseases are often persistently misdiagnosed or undiagnosed\, potentially resulting in no treatment at all or treatments that are ineffective or unsafe.  Due to the lack of definitive diagnostics or efficacious and safe therapies\, foundations and research centers have been raising funds for re-purposing existing therapeutics or developing new drugs (typically classified with an orphan drug status*).  As the development of biomarkers and genetic signatures continues to progress\, techniques and technologies are anticipated to become more precise and comprehensive\, thereby reducing the time to rare disease diagnoses (see related PMLS on May 11). \nSuch innovations at universities and medium to smaller companies has subsequently led to hundreds of clinical trials to test biomarkers\, gene signatures\, and new treatments.** Recruitment for these trials is complicated by identifying and making those eligible aware of enrollment. Therefore\, design and structure of orphan drug trials for small\, dispersed populations for efficient trial recruitment and execution are areas of great interest.  Due to the nature of these diseases\, data submission and review of successful trials are often allowed expedited review to speed access of drugs to patients and relief for families. \nIf you work in rare diseases or rare disorders\, this conference is one you cannot miss. Come and hear talks and discussions by leaders in academia\, biotech\, pharmaceuticals\, diagnostics\, clinical research\, informatics\, healthcare and regulatory bodies at the world’s most informative virtual conference on the following topics and more: \nExperiences from all parties – patient journeys\, doctors’ consultations\, payer perspectives\nRecruiting rare disease patients for clinical trials\nInterfaces and graphics that convey information through remote access to providers and patients\nTools that allow online access for patients\, doctors\, data sets\, multi-participant meetings\nChallenges of treating rare disease patients and families during a pandemic\nOnline support groups for sharing information among families and patients\nHow large\, medium\, and small companies in pharma\, clinical\, and diagnostic groups are addressing rare disease challenges\, including translational medicine\, data analysis\, economic modeling\, real-world data capture\nPartnerships among diagnostics companies\, pharmas\, payers\, and CROs for connected online resources\nPositioning rare disease services for coverage by payers\nWho should attend: \nExecutives and Decision Makers – CEOs\, CTOs\, CMOs\, and CSOs\nResearch\, Development\, and Practicing Clinicians\nBiomarker and Diagnostics Developers\nClinicians and practitioners who use telehealth\nTranslation Medicine\nFee and Payer Models\nDiagnostics Purchasers\, Sales\, and Planning\nRegulatory Leaders in Government and Business Affairs groups\nMarketing Leaders\nPayers\, Medical and Pharmacy Directors\, Actuaries\, CFO\nData analytics and informatics specialists\n Websites of interest \nRare Disease Day\, https://www.rarediseaseday.org/ \n*Designating an Orphan Product: Drugs and Biological Products\, https://www.fda.gov/industry/developing-products-rare-diseases-conditions/designating-orphan-product-drugs-and-biological-products \n**See rare disease\, rare disorder\, orphan drug on ClinicalTrials.gov at https://clinicaltrials.gov/ct2/home
URL:https://thebiocalendar.com/event/precision-medicine-rare-disease/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/02/Rare-Disease-Linkedin-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210610
DTEND;VALUE=DATE:20210612
DTSTAMP:20260608T192700
CREATED:20210413T191317Z
LAST-MODIFIED:20210413T191701Z
UID:1920-1623283200-1623455999@thebiocalendar.com
SUMMARY:BIO Digital
DESCRIPTION:Join The World’s Largest Global Biotech Partnering Experience\nBIO Digital is the world’s largest virtual biotech partnering and education event\, convening thousands of global biotech leaders and innovators. Join us in our efforts to accelerate a BIO-Revolution through global partnerships\, collaboration\, and thought leadership. \nNow more than ever\, the world is counting on us to come together to advance innovation and discovery.  Join us at BIO Digital 2021 this June! \nBIO Digital\nJune 10-11 & 14-18\, 2021
URL:https://thebiocalendar.com/event/bio-digital/
END:VEVENT
END:VCALENDAR